Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Long-acting injectable PrEP could offer an alternative to daily oral PrEP, improve adherence and protection, if found acceptable, safe and effective. HPTN 077 evaluated injectable cabotegravir safety, tolerability and pharmacokinetics among HIV-uninfected males and females in sequentially-enrolled c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Behav
Main Authors: Tolley, Elizabeth E., Zangeneh, Sahar Z., Chau, Gordon, Eron, Joe, Grinsztejn, Beatriz, Humphries, Hilton, Liu, Albert, Siegel, Marc, Bertha, Maseko, Panchia, Ravindre, Li, Sue, Cottle, Leslie, Rinehart, Alex, Margolis, David, Jennings, Andrea, McCauley, Marybeth, Landovitz, Raphael J.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7423859/
https://ncbi.nlm.nih.gov/pubmed/32052214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02808-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados